Cholesterol Newswire

Comprehensive Real-Time News Feed for Cholesterol.

Results 1 - 20 of 641 in Cholesterol

  1. Esperion Jumps on High-Cholesterol Drug DataRead the original story w/Photo

    11 hrs ago | Pharmaceutical Processing

    Shares of Esperion Therapeutics surged in aftermarket trading Wednesday after the company reported positive clinical trial results for its experimental high-cholesterol drug ETC-1002. The company said patients who were treated with ETC-1002 had bigger reductions in their levels of "bad" LDL cholesterol than patients who took an older drug, Merck & Co.'

    Comment?

  2. Esperion price target raised to $38 from $26 at Credit SuisseRead the original story

    Thursday Sep 25 | Theflyonthewall.com

    ... that even after the recent rally, Esperion's market cap of $500M "significantly" undervalues the company's cholesterol-lowering drug. It keeps a Buy rating on the name. Esperion spikes higher in the extended session, levels to watch Shares have ...

    Comment?

  3. Esperion jumps on high-cholesterol drug dataRead the original story

    19 hrs ago | Hispanic Business

    The company said patients who were treated with ETC-1002 had bigger reductions in their levels of "bad" LDL cholesterol than patients who took an older drug, Zetia. Patients who took a smaller dose of the drug had a 27-percent reduction in LDL cholesterol, and patients given a larger dose had a 30-percent reduction.

    Comment?

  4. On The Fly: After Hours MoversRead the original story

    Wednesday Sep 17 | Theflyonthewall.com

    Esperion cholesterol drug a blockbuster if approved, says Citigroup Citigroup believes Esperion's cholesterol lowering drug ETC-1002 is an inevitable blockbuster if approved. Citi views the company's market cap as disproportionate to the remaining risks around the drug.

    Comment?

  5. Esperion shares rally on cholesterol drug study resultsRead the original story

    19 hrs ago | MarketWatch

    Esperion shares surged 38% to $33.65 on moderate volume after the company said its cholesterol drug candidate ETC-1002 significantly lowered low-density lipoprotein cholesterol levels better than ezetimibe, which is marketed by Merck & Co.

    Comment?

  6. Esperion Therapeutics' cholesterol drug successful in Phase 2Read the original story w/Photo

    19 hrs ago | Seeking Alpha

    In a 348-patient Phase 2b clinical trial , Esperion Therapeutics' product candidate for hypercholesterolemia, ETC-1002 , achieved the primary endpoint of greater LDL-cholesterol lowering from baseline compared to ezetimibe . In patients who received ETC-1002 as monotherapy, the group treated with doses of 120 mg demonstrated a 27% reduction in LDL-cholesterol.

    Comment?

  7. Chewing the fat about high cholesterolRead the original story

    19 hrs ago | Northeasttimes.com

    When most people go to see their primary care physician, they will inevitably have a discussion on their cholesterol or lipid panel. This is a set of laboratory studies that includes cholesterol subtypes minimally including LDL, HDL and triglyceride cholesterol.

    Comment?

  8. After Hours: Esperion shares rally on cholesterol drug studyRead the original story

    20 hrs ago | MarketWatch

    Shares of Esperion Therapeutics Inc. rallied after the drug developer said its treatment significantly lowered bad cholesterol in patients enrolled in a clinical trial. shares rallied 32% to $32.20 on moderate volume after the drug developer said its cholesterol drug candidate, ETC-1002, significantly lowered low-density lipoprotein cholesterol levels in mid-stage clinical-trial participants compared to ezetimibe, which is marketed by Merck & Co.

    Comment?

  9. Esperion ETC-1002-008 Phase 2b study meets primary endpointRead the original story

    Thursday Sep 25 | Theflyonthewall.com

    ... support, a move down to common options strike prices such as $32.50 to $30 may establish support. Esperion cholesterol drug a blockbuster if approved, says Citigroup Citigroup believes Esperion's cholesterol lowering drug ETC-1002 is an inevitable ...

    Comment?

  10. Pumpkins Are More than Just a Halloween StapleRead the original story w/Photo

    Yesterday | Examiner.com

    ... brightly colored fruit are naturally rich in phytosterols. Phytosterols have been shown in studies to reduce LDL cholesterol for a healthy heart as well as promote a healthy prostate in men. One half cup of pumpkin has 6 milligrams of vitamin C. ...

    Comment?

  11. Genomic data could help doctors know whether to prescribe statinsRead the original story w/Photo

    Tuesday | Science Daily

    Genomic data could predict whether statins will benefit a patient or not, according to a new article. The research suggests that genomic data alone can explain around 15 percent of patients' responses to a cholesterol-lowering statin, and further studies could increase the accuracy of these predictions.

    Comment?

  12. Genetic data could help doctors know whether to prescribe statins or notRead the original story w/Photo

    Tuesday | Medical News Today

    Genomic data could predict whether statins will benefit a patient or not, according to an article in the open access journal Genome Biology . The research suggests that genomic data alone can explain around 15% of patients' responses to a cholesterol-lowering statin, and further studies could increase the accuracy of these predictions.

    Comment?

  13. Pharmaceutical companies conspired to keep more affordable generic...Read the original story w/Photo

    Monday | NewsTarget.com

    ... an agreement that Teva would instead be allowed to produce a generic version of another unrelated drug for cholesterol, known as Tricor. "We believe the defendants' anticompetitive conduct has forced consumers to overpay hundreds of millions of ...

    Comment?

  14. Esperion cholesterol drug a blockbuster if approved, says CitigroupRead the original story

    Thursday Sep 25 | Theflyonthewall.com

    Esperion cholesterol drug a blockbuster if approved, says Citigroup Citigroup believes Esperion's cholesterol lowering drug ETC-1002 is an inevitable blockbuster if approved. Citi views the company's market cap as disproportionate to the remaining risks around the drug.

    Comment?

  15. MomentumWE have OvercomeRead the original story

    Sunday Sep 28 | American Reporter

    We made food history last week when Indiana declared the Wick's sugar cream as its very own State Pie. I celebrated the event by having my wife tell me I couldn't eat any because of my cholesterol.

    Comment?

  16. Perspective: Ready to live but not to dieRead the original story w/Photo

    Friday Sep 26 | St. Petersburg Times

    ... of prevention are not worth the risks and hassles of testing, surgeries and medications. Recent guidelines for cholesterol treatment from the American College of Cardiology and the American Heart Association, for example, set 79 years as the upper ...

    Comment?

  17. Sovaldi's High Price Reflects a Trend, Not an Exception to the RuleRead the original story

    Friday Sep 26 | P&T Community

    ... Part of the reason can be attributed to the patent cliff peak during that period. Patents were lost for the cholesterol treatment Lipitor (atorvastatin, Pfizer), for the blood thinner Plavix (clopidogrel, Sanofi), and for the diabetes drug Actos ...

    Comment?

  18. Cardiology leaders call for global prevention of heart disease, strokeRead the original story w/Photo

    Friday Sep 26 | PhysOrg Weblog

    ... may be an effective low-cost strategy to improve adherence to medication recommendations ... New guidelines on cholesterol treatment and cardiovascular risk assessment state that men have at least double the risk of dying from atherosclerotic ...

    Comment?

  19. Reality check: Are low carb diets better than low fat for weight loss?Read the original story w/Photo

    Friday Sep 26 | GlobalNews

    Which is better for weight loss - a low-fat or low-carbohydrate diet? It's a question U.S. researchers attempted to answer, unknowingly unleashing an uproar from supporters dedicated to both diets. Low-carb and low-fat diets each have a cult-like following.

    Comment?

  20. 10 Super Foods that Help HeartburnRead the original story w/Photo

    Thursday Sep 25 | Natural Holistic Health

    ... immediately after eating a meal. Make your morning meal oatmeal. It's high in fiber, low in saturated fat and cholesterol and when combined with skim milk, gives you a calcium-charged boost to your day. By adding blueberries or raisins you'll be ...

    Comment?